DongKook Pharmaceutical Co., Ltd.
Financials
Valuation Metrics
DongKook Pharmaceutical Co., Ltd.'s Market Cap is ₩9453B. At end of 2025 it was ₩7757B. Ranked #306 of 2,421 in KR market (top 13%), #82 of 1,640 on KOSDAQ (top 5%), #33 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 14%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 945.32B KRW | KR#306/2,421 Sec#33/231 |
| Revenue | 979.60B KRW | KR#418/2,421 Sec#15/231 |
| Net Income | 81.46B KRW | KR#288/2,421 Sec#18/231 |
| Total Assets | 1.12T KRW | KR#452/2,421 Sec#24/231 |
| Net Assets | 797.63B KRW | KR#347/2,421 Sec#21/231 |
| Employees | 1,216 | KR#212/2,421 Sec#13/231 |
| Value | ||
| P/E | 11.60x | KR#904/2,421 Sec#50/231 |
| P/B | 1.19x | KR#1,610/2,421 Sec#107/231 |
| PEG | 0.42x | KR#676/2,421 Sec#44/231 |
| P/S | 0.96x | KR#1,365/2,421 Sec#83/231 |
| EV/EBITDA | 9.15x | KR#560/2,421 Sec#24/231 |
| FCF Yield | 2.76% | KR#1,008/2,421 Sec#62/231 |
| Profitability | ||
| ROE | 10.21% | KR#595/2,421 Sec#42/231 |
| ROA | 7.29% | KR#490/2,421 Sec#37/231 |
| Op. Margin | 10.47% | KR#496/2,421 Sec#44/231 |
| Revenue Growth | 12.73% | KR#772/2,421 Sec#75/231 |
| Earnings Growth | 27.37% | KR#663/2,421 Sec#44/231 |
| Financial Health | ||
| Debt Ratio | 40.12% | KR#790/2,421 Sec#92/231 |
| Total Debt | 67.26B KRW | KR#885/2,421 Sec#60/231 |
| FCF | 26.05B KRW | KR#448/2,421 Sec#26/231 |
| Cash | 74.46B KRW | KR#582/2,421 Sec#30/231 |
| Current Ratio | 2.05x | KR#847/2,421 Sec#95/231 |
| Net Debt/EBITDA | -0.07x | KR#588/2,421 Sec#35/231 |
| Dividend | ||
| Div. Yield | 0.97% | KR#1,128/2,421 Sec#65/231 |
| Div. Growth | 0.00% | KR—/2,421 Sec—/231 |
| Performance | ||
| 1Y Return | 10.52% | KR#564/2,421 Sec#34/231 |
| 1M Return | 16.11% | KR#304/2,421 Sec#17/231 |
| From 52W High | -33.12% | KR#642/2,421 Sec#38/231 |
| 1Y MDD | -44.68% | KR#759/2,421 Sec#60/231 |
| Trading | ||
| Volume | 245,253 shares | KR#414/2,421 Sec#24/231 |
| Trading Value | 5.14B KRW | KR#360/2,421 Sec#34/231 |
| Foreign Own. | 10.97% | KR#443/2,421 Sec#37/231 |
| Per Share | ||
| EPS | 1,801 KRW | KR#483/2,421 Sec#29/231 |
| BPS | 17,635 KRW | KR#598/2,421 Sec#39/231 |
Company Info
Dongguk Pharmaceutical, established in 1968 and listed on KOSDAQ in 2007, is a pharmaceutical company with subsidiaries including Dongguk Pharmaceutical Life Science. It manufactures and sells over-the-counter drugs, prescription drugs, and active pharmaceutical ingredients, alongside supplying cosmetics, health functional foods, and household goods domestically and internationally. The company has built a strong production base through mass production of natural material ingredients, automated warehouses, and secure manufacturing spaces. It is expanding into a global pharmaceutical company by exporting new platform technology products overseas. The company is headquartered in Gangnam-gu, Seoul.